Name the group which has launched the generic Favipiravir in India under the brand Favivir in India to treat Covid-19 infected patients.

2020

Please wait while the activity loads.
If this activity does not load, try refreshing your browser. Also, this page requires javascript. Please visit using a browser with javascript enabled.

If loading fails, click here to try again

Question [CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]

Name the group which has launched the generic Favipiravir in India under the brand ‘Favivir’ in India to treat Covid-19 infected patients.

A	Lupin
B	Cipla
C	Sun
D	Hetero

Explanation:

Detailed explanation-1: -Seven Indian companies - Mylan, Hetero, Jubiliant Life Sciences, Cipla, Dr Reddy’s, Zydus Cadila and Sun Pharma – produce Remdesivir injections under licensing agreement with Gilead Sciences.

Detailed explanation-2: -The oral antiviral treatments for COVID-19, Paxlovid® and Lagevrio®, are listed on the Pharmaceutical Benefits Scheme (PBS).

Detailed explanation-3: -Remdesivir is an inhibitor of the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp), which is essential for viral replication. Remdesivir is an adenosine nucleotide prodrug that is metabolized to the pharmacologically active nucleoside triphosphate metabolite after being distributed into cells.

There is 1 question to complete.